Edition:
United States

Shire PLC (SHP.L)

SHP.L on London Stock Exchange

4,406.50GBp
11:53am EDT
Change (% chg)

48.50 (+1.11%)
Prev Close
4,358.00
Open
4,410.00
Day's High
4,436.00
Day's Low
4,389.00
Volume
1,446,028
Avg. Vol
2,078,248
52-wk High
4,662.00
52-wk Low
2,940.50

Chart for

About

Shire plc is a biotech company focused on serving people with rare diseases and other specialized conditions. The Company's segment is engaged in research, development, licensing, manufacturing, marketing, distribution and sale of specialist medicines. It focuses its development resources on projects in various therapeutic areas... (more)

Overall

Beta: 1.36
Market Cap(Mil.): £40,242.43
Shares Outstanding(Mil.): 914.73
Dividend: 4.26
Yield (%): --

Financials

  SHP.L Industry Sector
P/E (TTM): 21.54 29.75 32.14
EPS (TTM): 2.04 -- --
ROI: 4.06 13.18 12.83
ROE: 7.16 15.14 14.95

With Hemlibra, Roche seeks to break into tight hemophilia circle

ZURICH Swiss drugmaker Roche is breaking into hemophilia A treatment, a $10 billion global market dominated by rivals who have cultivated close ties to sufferers of the genetic bleeding disorder.

Oct 03 2018

Takeda's $62 billion Shire bid faces November 6 EU antitrust deadline

BRUSSELS EU antitrust regulators will decide by Nov. 6 whether to allow Japanese drugmaker Takeda Pharmaceutical's $62-billion takeover of London-listed Shire Plc , the European Commission said on Friday.

Sep 28 2018

Takeda's $62 bln Shire bid faces Nov. 6 EU antitrust deadline

BRUSSELS, Sept 28 EU antitrust regulators will decide by Nov. 6 whether to allow Japanese drugmaker Takeda Pharmaceutical's $62-billion takeover of London-listed Shire Plc, the European Commission said on Friday.

Sep 28 2018

Deal-making spree keeps investors upbeat about European M&A revival

MILAN, Sept 26 The $40 billion takeover of British broadcaster Sky and other new deals in Europe have broken a summer lull to bolster investor optimism over an M&A revival in the region.

Sep 26 2018

UPDATE 1-UK Stocks-Factors to watch on Sept 17

(Adds company news items and futures) Britain's FTSE 100 index is seen opening 11 points lower at 7,293 on Monday, according to financial bookmakers, with FTSE 100 futures down 0.26 percent ahead of the cash market open.

Sep 17 2018

UK Stocks-Factors to watch on Sept 17

Britain's FTSE 100 index is seen opening 11 points lower at 7,293 on Monday, according to financial bookmakers. * GOLD: Gold inched up on Monday as bargain-hunters bought the metal after prices dipped in the previous session, amid reports that the United States is set to impose a new round of tariffs on Chinese imports. * OIL: Global oil prices eased in early Asian trading on Monday on concerns that the United States is poised to impose additional tariffs on China, outweighing supply fea

Sep 17 2018

UPDATE 1-FTSE tracks Europe higher; Shire shines

MILAN, Sept 14 Britain's top share index tracked higher European markets on Friday with the mood buoyed by easing trade worries, while Shire rose after China cleared Takeda's plans to buy the drugmaker.

Sep 14 2018

FTSE tracks Europe higher on trade hopes; Shire shines

MILAN, Sept 14 Britain's top share index tracked higher European markets on Friday with the mood buoyed by easing trade worries, while Shire rose after China cleared Takeda's plans to buy the drugmaker.

Sep 14 2018

Takeda gets China's approval for $62 billion Shire purchase

Takeda Pharmaceutical Co Ltd said on Friday China approved its purchase of Shire Plc, the latest regulator to clear the $62 billion deal and bring the Japanese group closer to becoming a global top 10 drugmaker.

Sep 14 2018

UPDATE 1-Takeda gets China's approval for $62 bln Shire purchase

* Takeda still awaiting approval from EU, Japan (Adds background, share price)

Sep 14 2018

Earnings vs. Estimates